Massive study tracks malaria Vaccine's Real-World shield for kids
NCT ID NCT03855995
Summary
This large study monitored the safety and real-world performance of the RTS,S malaria vaccine after it was introduced into routine childhood immunization programs in sub-Saharan Africa. Researchers followed over 77,000 young children, comparing health outcomes between those who received the vaccine and those who did not. The goal was to confirm the vaccine's safety profile and measure how well it prevented malaria, severe illness, and hospitalizations in everyday use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Kintampo, Ghana
-
GSK Investigational Site
Navrongo, Ghana
-
GSK Investigational Site
Kisumu, 4 0100, Kenya
-
GSK Investigational Site
Kisumu, 40100, Kenya
-
GSK Investigational Site
Chikwawa, Malawi
-
GSK Investigational Site
Mangochi, Malawi
Conditions
Explore the condition pages connected to this study.